NH
NantHealth Inc
Price:  
1.35 
USD
Volume:  
232,491.00
United States | Health Care Technology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NH EV/EBITDA

-8453.6%
Upside

As of 2025-07-07, the EV/EBITDA ratio of NantHealth Inc (NH) is -8.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NH's latest enterprise value is 336.09 mil USD. NH's TTM EBITDA according to its financial statements is -37.78 mil USD. Dividing these 2 quantities gives us the above NH EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 9.2x - 12.5x 11.8x
Forward P/E multiples 11.7x - 20.1x 17.0x
Fair Price (99.46) - (103.78) (112.77)
Upside -7467.4% - -7787.0% -8453.6%
1.35 USD
Stock Price
(112.77) USD
Fair Price

NH EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA